home / stock / dcth / dcth news


DCTH News and Press, Delcath Systems Inc. From 03/15/24

Stock Information

Company Name: Delcath Systems Inc.
Stock Symbol: DCTH
Market: OTC
Website: delcath.com

Menu

DCTH DCTH Quote DCTH Short DCTH News DCTH Articles DCTH Message Board
Get DCTH Alerts

News, Short Squeeze, Breakout and More Instantly...

DCTH - Delcath Systems Announces $7 Million Private Placement

Delcath Systems Announces $7 Million Private Placement PR Newswire NEW YORK , March 15, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today an...

DCTH - Delcath Systems Announces Healthcare Setting Locator for HEPZATO(TM) KIT (melphalan/Hepatic Delivery System)

Delcath Systems Announces Healthcare Setting Locator for HEPZATO™ KIT (melphalan/Hepatic Delivery System) PR Newswire NEW YORK , Feb. 22, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treat...

DCTH - Delcath Systems announces CMS established product-specific J-code for HEPZATO

2024-01-31 09:14:13 ET More on Delcath Systems Adoption Of Delcath's Hepzato Kit Will Snowball Quicker Than The Market Expects Delcath Systems Inc. (DCTH) Q3 2023 Earnings Call Transcript Delcath launches Hepzato Kit in US for uveal melanoma Delcath Systems Q...

DCTH - Delcath Systems Receives Permanent J-Code (J9248) for HEPZATO(TM) (melphalan/Hepatic Delivery System) Effective April 1, 2024

Delcath Systems Receives Permanent J-Code (J9248) for HEPZATO™ (melphalan/Hepatic Delivery System) Effective April 1, 2024 PR Newswire NEW YORK , Jan. 31, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company foc...

DCTH - Delcath Systems to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference

Delcath Systems to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference PR Newswire NEW YORK , Jan. 23, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of ...

DCTH - Delcath launches Hepzato Kit in US for uveal melanoma

2024-01-16 09:43:50 ET More on Delcath Systems Adoption Of Delcath's Hepzato Kit Will Snowball Quicker Than The Market Expects Delcath Systems Inc. (DCTH) Q3 2023 Earnings Call Transcript Delcath Systems Q3 2023 Earnings Preview Seeking Alpha’s Quant R...

DCTH - Delcath Systems Announces U.S. Launch and First Commercial Treatment Utilizing HEPZATO KIT(TM)

Delcath Systems Announces U.S. Launch and First Commercial Treatment Utilizing HEPZATO KIT™ PR Newswire NEW YORK , Jan. 16, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primar...

DCTH - Penny Stocks To Buy Now? 4 To Watch Before 2024

2023-12-19 10:11:12 ET Penny Stocks and Preparing for 2024 As we enter 2024, investors wonder if it will be another volatile year for stocks. Maybe we see some stabilization after 2023’s ups and downs; maybe not. For those interested in penny stocks, the high-risk but potentially...

DCTH - Delcath Systems CEO discloses purchase of 34K shares

2023-12-12 11:12:22 ET More on Delcath Systems Adoption Of Delcath's Hepzato Kit Will Snowball Quicker Than The Market Expects Seeking Alpha’s Quant Rating on Delcath Systems Historical earnings data for Delcath Systems For further details see: Del...

DCTH - Delcath Systems Announces Publication by Independent Investigators of a Retrospective Analysis of Quality of Life in the Journal Melanoma Research

Delcath Systems Announces Publication by Independent Investigators of a Retrospective Analysis of Quality of Life in the Journal Melanoma Research PR Newswire Retrospective Analysis of Changes in Patients with Metastatic Uveal Melanoma treated with Chemosat Hepatic Delivery Sy...

Previous 10 Next 10